189.272 articles found

Investigation of cortical cholinergic projection integrity in relation to longitudinal cognitive performance in Parkinson's disease

Slater N, Myall D, Horne K, Heron C, Keenan R, Kirk I, Meissner W, Anderson T, Melzer T, Dalrymple‐Alford J.

Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025-12-01

Magnetic resonance molecular imaging of neuroinflammation in mouse models of Alzheimer's and Parkinson's diseases by precision targeting of CSF1‐R

Sun X, Badachhape A, Reid T, Chin J, Shulman J, Annapragada A, Lowe H, Toyang N, Tanifum E.

Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025-12-01

Exploratory Study on the Role of Emodin in Alleviating MPTP-Induced Neurotoxicity: A Focus on p53-Ferroptosis Signaling.

Chen Y, Zhao Y, Wang Q, Chen Q, Chen X, Yang K.

Drug Des Devel Ther · 2025-12-01

DOI: 10.2147/dddt.s522381PMID: 41356603

Effects of Rehabilitative Device on Parkinsonian Gait.

Ray BN, Ustinova KI, Langenderfer JE.

Int J Exerc Sci · 2025-12-01

PMID: 41378232

Decoding the therapeutic potential mechanism of <i>Cornus officinalis</i> in Parkinson's disease: a network pharmacology insight.

Wu Z, Zhao J, Wang W, Dong Y, Zhou T, Feng Y, Deng Y, Feng Y.

Front Pharmacol · 2025-12-01

DOI: 10.3389/fphar.2025.1714796PMID: 41403435

Impact of aging on the central and enteric nervous system in a Parkinson's disease mouse model.

Pradeloux S, André MM, Fréchette M, Drolet M, Fontaine-Lavallée C, Côté M, Coulombe K, Rieux M, Calon F, Soulet D.

Front Aging Neurosci · 2025-12-01

DOI: 10.3389/fnagi.2025.1576325PMID: 41403905

The locus coeruleus, a blue spot for early diagnosis and prognosis of Alzheimer's disease.

Farahani F, Anaclet C, Azizi H, Gompf HS.

Front Aging Neurosci · 2025-12-01

DOI: 10.3389/fnagi.2025.1632236PMID: 41403903

GABAergic neurons are a key cell type in a <i>Drosophila</i> model of PARK14/<i>PLA2G6</i>-associated neurodegeneration.

Meimoun NS, Benji S, Besharim WZ, Cantor YY, Carroll ES, Coplin BI, Davidovics MB, Gerber M, Hirschprung PM, Jacobson EI, Levenbrown AL, Levitt DT, Levy A, Mazin YZ, Moskowitz AD, Purow JI, Rimberg A, Rothstein JE, Saks EY, Saperstein R, Scher YY, Schwarcz YD, Silver M, Stein YF, Wiener YY, Steinhauer J.

Front Neurosci · 2025-12-01

DOI: 10.3389/fnins.2025.1534243PMID: 41404033

Alterations in gut microbiota and plasma metabolites: a multi-omics study of mild cognitive impairment in Parkinson's disease.

Lin Z, Li Y, Liu Y, Yang B, Yin P, Guan C, Fang Y, Yang L, Zan K, Cui G, Yu L, Wang X, Xu C.

Front Neurosci · 2025-12-01

DOI: 10.3389/fnins.2025.1667331PMID: 41404035

Effectiveness and safety of magnetic resonance-guided unilateral focused ultrasound subthalamotomy for Parkinson's disease: a systematic review and meta-analysis of prospective studies.

Cheng B, Luo ZH, Xiao X, Che CF, Zhu T, Zhang SS.

Front Neurosci · 2025-12-01

DOI: 10.3389/fnins.2025.1693035PMID: 41404031

Interplay between lipid droplets and alpha-synuclein: implication in Parkinson's disease pathogenesis.

Idi W, Sheta R, Oueslati A.

Front Mol Neurosci · 2025-12-01

DOI: 10.3389/fnmol.2025.1681039PMID: 41404624

Cholinergic patterns correlate with dopamine medication ON freezing of gait in Parkinson's disease.

Hvingelby VS, Terkelsen MH, Johnsen EL, Møller M, Danielsen EH, Henriksen T, Glud AN, Tai YF, Møller Andersen AS, Knudsen AL, Meier K, Horsager J, Okkels N, Sørensen JCH, Borghammer P, Moro E, Pavese N.

Brain · 2025-12-01

DOI: 10.1093/brain/awaf231PMID: 40512756